| Title |
Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis
|
|---|---|
| Published in |
Drug Safety, October 2018
|
| DOI | 10.1007/s40264-018-0751-2 |
| Pubmed ID | |
| Authors |
Einat Gorelik, Reem Masarwa, Amichai Perlman, Victoria Rotshild, Momen Abbasi, Mordechai Muszkat, Ilan Matok |
X Demographics
The data shown below were collected from the profiles of 73 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 21 | 29% |
| United States | 4 | 5% |
| Mexico | 3 | 4% |
| Argentina | 2 | 3% |
| Paraguay | 1 | 1% |
| Chile | 1 | 1% |
| Ecuador | 1 | 1% |
| Belgium | 1 | 1% |
| New Zealand | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 35 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 69 | 95% |
| Practitioners (doctors, other healthcare professionals) | 2 | 3% |
| Scientists | 1 | 1% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 93 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 14 | 15% |
| Student > Ph. D. Student | 8 | 9% |
| Student > Postgraduate | 8 | 9% |
| Researcher | 7 | 8% |
| Student > Bachelor | 7 | 8% |
| Other | 17 | 18% |
| Unknown | 32 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 24% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 11% |
| Biochemistry, Genetics and Molecular Biology | 6 | 6% |
| Immunology and Microbiology | 5 | 5% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 12 | 13% |
| Unknown | 36 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2024.
All research outputs
#681,937
of 25,728,350 outputs
Outputs from Drug Safety
#46
of 1,872 outputs
Outputs of similar age
#14,705
of 362,853 outputs
Outputs of similar age from Drug Safety
#1
of 27 outputs
Altmetric has tracked 25,728,350 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,872 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.